Data reports intensity levels used during remote electrical neuromodulation sessions for migraine treatment in India, suggesting effective self-management.
Remote electrical neuromodulation (REN) is USFDA cleared device for acute and/or preventive treatment of migraine in patients aged 12 + years of age. Each device has 18 sessions and for each session, the patients are recommended to use the intensity levels, which is “strong but not painful’. Here we report the data of the intensity levels used by the migraine patients in India.
No takes yet. Share an insight, caveat, or question.
Biswas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: